A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations - PubMed (original) (raw)
. 2001 Sep 15;10(19):2171-9.
doi: 10.1093/hmg/10.19.2171.
H Woffendin, T Jakins, T Bardaro, T Esposito, A Smahi, C Shaw, M Levy, A Munnich, M D'Urso, R A Lewis, S Kenwrick, D L Nelson
Affiliations
- PMID: 11590134
- DOI: 10.1093/hmg/10.19.2171
A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations
S Aradhya et al. Hum Mol Genet. 2001.
Abstract
Incontinentia pigmenti (IP) is an X-linked dominant disorder characterized by abnormal skin pigmentation, retinal detachment, anodontia, alopecia, nail dystrophy and central nervous system defects. This disorder segregates as a male lethal disorder and causes skewed X-inactivation in female patients. IP is caused by mutations in a gene called NEMO, which encodes a regulatory component of the IkappaB kinase complex required to activate the NF-kappaB pathway. Here we report the identification of 277 mutations in 357 unrelated IP patients. An identical genomic deletion within NEMO accounted for 90% of the identified mutations. The remaining mutations were small duplications, substitutions and deletions. Nearly all NEMO mutations caused frameshift and premature protein truncation, which are predicted to eliminate NEMO function and cause cell lethality. Examination of families transmitting the recurrent deletion revealed that the rearrangement occurred in the paternal germline in most cases, indicating that it arises predominantly by intrachromosomal misalignment during meiosis. Expression analysis of human and mouse NEMO/Nemo showed that the gene becomes active early during embryogenesis and is expressed ubiquitously. These data confirm the involvement of NEMO in IP and will help elucidate the mechanism underlying the manifestation of this disorder and the in vivo function of NEMO. Based on these and other recent findings, we propose a model to explain the pathogenesis of this complex disorder.
Similar articles
- Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation.
Fusco F, Bardaro T, Fimiani G, Mercadante V, Miano MG, Falco G, Israël A, Courtois G, D'Urso M, Ursini MV. Fusco F, et al. Hum Mol Genet. 2004 Aug 15;13(16):1763-73. doi: 10.1093/hmg/ddh192. Epub 2004 Jun 30. Hum Mol Genet. 2004. PMID: 15229184 - Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma).
Aradhya S, Courtois G, Rajkovic A, Lewis RA, Levy M, Israël A, Nelson DL. Aradhya S, et al. Am J Hum Genet. 2001 Mar;68(3):765-71. doi: 10.1086/318806. Epub 2001 Feb 8. Am J Hum Genet. 2001. PMID: 11179023 Free PMC article. - Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, Israël A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A, Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D'Urso M, Woffendin H, Jakins T, Donnai D, Stewart H, Kenwrick SJ, Aradhya S, Yamagata T, Levy M, Lewis RA, Nelson DL. Smahi A, et al. Nature. 2000 May 25;405(6785):466-72. doi: 10.1038/35013114. Nature. 2000. PMID: 10839543 - NEMO gene rearrangement (exon 4-10 deletion) and genotype-phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients.
Okita M, Nakanishi G, Fujimoto N, Shiomi M, Yamada T, Wataya-Kaneda M, Takijiri C, Yokoyama Y, Sunohara A, Tanaka T. Okita M, et al. J Dermatol. 2013 Apr;40(4):272-6. doi: 10.1111/1346-8138.12091. Epub 2013 Feb 11. J Dermatol. 2013. PMID: 23398170 Review. - Incontinentia pigmenti (Bloch-Sulzberger syndrome).
Narayanan MJ, Rangasamy S, Narayanan V. Narayanan MJ, et al. Handb Clin Neurol. 2015;132:271-80. doi: 10.1016/B978-0-444-62702-5.00020-2. Handb Clin Neurol. 2015. PMID: 26564087 Review.
Cited by
- Identification of a 650 kb duplication at the X chromosome breakpoint in a patient with 46,X,t(X;8)(q28;q12) and non-syndromic mental retardation.
Cox JJ, Holden ST, Dee S, Burbridge JI, Raymond FL. Cox JJ, et al. J Med Genet. 2003 Mar;40(3):169-74. doi: 10.1136/jmg.40.3.169. J Med Genet. 2003. PMID: 12624134 Free PMC article. - A case of subungual tumors of incontinentia pigmenti: A rare manifestation and association with bipolar disease.
Kibbi N, Totonchy M, Suozzi KC, Ko CJ, Odell ID. Kibbi N, et al. JAAD Case Rep. 2018 Aug 17;4(7):737-741. doi: 10.1016/j.jdcr.2018.03.018. eCollection 2018 Aug. JAAD Case Rep. 2018. PMID: 30167449 Free PMC article. No abstract available. - A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency.
Martinez-Pomar N, Munoz-Saa I, Heine-Suner D, Martin A, Smahi A, Matamoros N. Martinez-Pomar N, et al. Hum Genet. 2005 Dec;118(3-4):458-65. doi: 10.1007/s00439-005-0068-y. Epub 2005 Oct 14. Hum Genet. 2005. PMID: 16228229 - NEMO Gene Mutations in Two Chinese Females with Incontinentia Pigmenti.
Jiang J, Zeng J, He Q, Yang J, Wang S, Zhang Z. Jiang J, et al. Clin Cosmet Investig Dermatol. 2022 May 5;15:815-821. doi: 10.2147/CCID.S363683. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35547601 Free PMC article. - Hypertrichotic patches as a mosaic manifestation of Proteus syndrome.
Pithadia DJ, Roman JW, Sapp JC, Biesecker LG, Darling TN. Pithadia DJ, et al. J Am Acad Dermatol. 2021 Feb;84(2):415-424. doi: 10.1016/j.jaad.2020.01.078. Epub 2020 Feb 7. J Am Acad Dermatol. 2021. PMID: 32035943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous